|

PF-08634404 Clinical Trials

10 actively recruiting trials across 8 locations

No change since August 2026

Also known as: SSGJ-707

Pipeline

Phase 2: 2Phase 3: 2Phase 1/2: 4Phase 2/3: 2

Top Sponsors

  • Pfizer10

Indications

  • Cancer10
  • Lung Cancer5
  • Non Small Cell Lung Cancer3
  • Carcinoma, Non-Small-Cell Lung (NSCLC)2
  • Small Cell Lung Cancer (SCLC)2

Fayetteville, Arkansas3 trials

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Highlands Oncology Group, PA

Phase 1/2
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

Highlands Oncology Group

Phase 2/3
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Highlands Oncology Group, PA

Phase 1/2

Huntsville, Alabama1 trial

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Clearview Cancer Institute (Crestwood)

Phase 2

Bullhead City, Arizona1 trial

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Pioneer Research Center

Phase 3

Chandler, Arizona1 trial

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Ironwood Cancer & Research Centers

Phase 3

Phoenix, Arizona1 trial

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Mayo Clinic Building- Phoenix

Phase 1/2

Duarte, California1 trial

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

City of Hope National Medical Center

Phase 2

Irvine, California1 trial

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Chao Family Comprehensive Cancer Center and Ambulatory Care

Phase 1/2

Aurora, Colorado1 trial

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Rocky Mountain Cancer Centers, LLP

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.